Howard Mayer's Net Worth
$109 Thousand
Who is Howard Mayer?
Howard Mayer does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adagio Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., Entasis Therapeutics Holdings Inc., and PepGen Inc..
SEC CIK
Howard Mayer's CIK is 0001699610
Past Insider Trading and Trends
2021 was Howard Mayer's most active year for acquiring shares with 3 total transactions. Howard Mayer's most active month to acquire stocks was the month of May. 2022 was Howard Mayer's most active year for disposing of shares, totalling 4 transactions. Howard Mayer's most active month to dispose stocks was the month of June. 2022 saw Howard Mayer paying a total of $0.00 for 102,500 shares, this is the most they've acquired in one year. In 2022 Howard Mayer cashed out on 73,000 shares for a total of $108,900.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adagio Therapeutics, Inc. (IVVD) Snapshot price: $4.755
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GENOCEA BIOSCIENCES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -49.50K |
$2.20 | -$108,900.00 |
0
|
Jul 7 - Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
| +125.00% | 27.5K |
—
|
—
| 49.5K |
Jan 18
| |||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PepGen Inc. (PEPG) Snapshot price: $12.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |